Key statistics
On Monday, Femasys Inc (FEMY:NAQ) closed at 1.10, 49.86% above the 52 week low of 0.734 set on Jan 31, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.08 |
---|---|
High | 1.20 |
Low | 1.06 |
Bid | 1.07 |
Offer | 1.15 |
Previous close | 1.05 |
Average volume | 195.19k |
---|---|
Shares outstanding | 22.23m |
Free float | 20.54m |
P/E (TTM) | -- |
Market cap | 23.34m USD |
EPS (TTM) | -0.8253 USD |
Data delayed at least 15 minutes, as of Nov 25 2024 20:59 GMT.
More ▼
- Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update
- Femasys to Exhibit at the Annual AAGL 2024 Global Conference
- Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control
- Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed
- Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program
- Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
- Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments
- Femasys Announces Infertility Clinic Customers from Coast to Coast
- Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market
- Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check
More ▼